Next, WT1/HLA-A2-specific CTL (hereon abbreviated as WT1-CTL) cytotoxicity was assessed against a panel of HLA-A*02:01-positive AML cell lines: OCI-AML2, OCI-AML3, and THP-1. The gene discussed is WT1; the disease is acute myeloid leukemia.